How weight loss drugs took over Instagram
In one hand, a slender young woman holds up a bottle of clear liquid. The words “Skinny” and “GLP-1” — a new class of weight loss drugs — are visible on the label. In the other hand, she raises up a pipette filled with the liquid, as if to drop it in her open mouth. “Lose up to 15% of your body weight,” reads the caption on the Instagram post.
New FDA Warning Added to Popular Weight Loss Drugs
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration during general anesthesia or deep sedation. The affected drugs are liraglutide (Saxenda, Victoza), semaglutide (Ozempic, Rybelsus, Wegovy), and tirzepatide (Mounjaro, Zepbound).
The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
The odds for aspiration is greatest in the first weeks after a GLP-1 med is prescribed, since the delay in stomach emptying ...
Drugs that belong to the class of GLP-1 receptor agonists could cause muscle loss These drugs reduce appetite and are ...
Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...
Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) prior to bariatric surgery was safe but wasn’t associated with ...
Powers Health surgical and medical weight-loss services in Hobart and Munster provide tailored support and experts who ...
As open enrollment kicks off, employees may find an unpleasant surprise in their 2025 health insurance premiums. Increased adoption of GLP-1 drugs, rising catastrophic claims and other cost pressures ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback